查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
奎宁全球市场 - 全球产业分析、规模、份额、成长、趋势、区域展望、预测 (2023-2030)
市场调查报告书
商品编码
1385612

奎宁全球市场 - 全球产业分析、规模、份额、成长、趋势、区域展望、预测 (2023-2030)

Quinine Market - Global Quinine Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030
出版日期: | 出版商: Fairfield Market Research | 英文 236 Pages | 商品交期: 2-5个工作天内

价格
简介目录

在健康意识和认可度不断提高的推动下，全球奎宁市场规模预计在未来几年将大幅成长。 该市场预计将从2022年的约21亿美元成长到2030年的32亿美元，2023年至2030年的复合年增长率为6.5%。

含有奎宁的汤力水作为一种健康饮料在世界各地越来越受欢迎。 由于奎宁具有治疗疟疾和缓解腿部抽筋等优异的治疗特性，全球对汤力水的需求不断增长，奎宁的市场正在扩大。

全球疟疾病例数量正在迅速增加，2020年报告的新病例超过1400万例，是自2012年以来的最高水准。 奎宁是治疗疟疾的有效药物，随着疟疾患者的增加，预计需求也会增加。

奎宁是杜松子酒和滋补品等苦味酒精饮料的关键成分，在全球范围内越来越受欢迎。 这一趋势，加上啤酒、葡萄酒和烈酒等酒精饮料的日益普及，正在推动奎宁的销售。

奎宁通常是作为酒精饮料的混合剂出售，但作为一种可用于多种用途的多功能产品并不广为人知。 发烧、头痛和视力问题等健康併发症与奎宁的消费有关，可能会影响市场成长。

本报告调查了全球奎宁市场，并提供了市场概况，包括按类型、应用、剂量、最终用户、地区以及进入市场的公司的竞争趋势划分的趋势。我是。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2030 年全球奎宁市场展望

  • 2018-2030 年全球奎宁市场前景（按类型和价值划分）（百万美元）
  • 2018-2030 年全球奎宁市场前景（按应用、金额（百万美元））
  • 2018-2030 年全球奎宁市场展望（按剂量、价值（百万美元））
  • 2018-2030 年全球奎宁市场展望，按最终用户划分，价值（百万美元）
  • 2018-2030 年全球奎宁市场展望（按地区、价值（百万美元））

第 4 章 2018-2030 年北美奎宁市场展望

第五章欧洲奎宁市场展望，2018-2030

第 6 章 2018-2030 年亚太地区奎宁市场展望

第 7 章拉丁美洲奎宁市场展望，2018-2030

第 8 章中东与非洲奎宁市场展望，2018-2030

第九章竞争态势

  • 製造商和应用程式的热图
  • 2022 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Aecochem Corp
    • Haihang Industry Co. Ltd.
    • Actavis
    • Shreeji Pharma International
    • Wockhardt
    • Vital Labs
    • Trademax Pharmaceuticals & Chemicals
    • Van Wankum Ingredients
    • Hangzhou Dayang Co. Ltd.
    • IS Chemical Technology Ltd.
    • Leocorno Enterprises
    • Bickford & Sons
    • Fever-Tree
    • Schweppes
    • Chempro Pharma Private Limited

第 10 章附录

简介目录

The global quinine market, driven by increasing health consciousness and rising awareness, is expected to witness substantial growth in the coming years. According to a recent report by Fairfield Market Research, the market was valued at approximately US$2.1 billion in 2022 and is projected to reach US$3.2 billion by 2030, with a CAGR of 6.5% between 2023 and 2030.

Market Drivers

Several key factors are contributing to the growth of the quinine market:

Increasing Demand for Tonic Water: Tonic water, containing quinine, is gaining popularity as a healthful beverage globally. With its exceptional therapeutic properties, including its use in malaria treatment and relieving leg cramps, quinine's market is expanding due to the rising global demand for tonic water.

Rising Cases of Malaria: The world has witnessed a surge in malaria cases, with over 14 million new cases reported in 2020, the highest levels since 2012. Quinine, an effective treatment for malaria, is expected to see increased demand due to the growing number of malaria patients.

Rising Alcoholic Beverage Consumption: Quinine is a key ingredient in some bitter alcoholic beverages like gin and tonic, which have gained popularity worldwide. This trend, along with the increasing popularity of alcoholic beverages like beer, wine, and spirits, is driving up the sales of quinine.

Market Challenges

Despite the promising growth, some challenges are impacting the quinine market:

Low Awareness Among Consumers: Quinine is often marketed as a mixer for alcoholic beverages, limiting its recognition as a versatile product with various uses.

Potential Health Issues: Some health complications, such as fever, headaches, and vision impairments, have been associated with quinine consumption, potentially affecting market growth.

Key Trends and Opportunities

The quinine market offers several opportunities for growth:

Product Innovations: Ongoing product innovation, including the use of quinine from natural sources and natural sweeteners, is expected to drive market expansion. Manufacturers are investing in research and development to create new flavors that cater to different consumer preferences.

Rising Consumer Spending Power: The increase in disposable income due to industrialization and economic progress is contributing to the growth of the quinine market. Urbanization and the influence of social media are also driving alcohol consumption and the demand for quinine.

Expanding Cocktail Culture: Tonic water is commonly used as a mixer in cocktails and mocktails, especially among gin and whisky drinkers. The growing cocktail culture is expected to open up new opportunities for the quinine sector.

Regional Outlook

North America: The North American region, including the U.S. and Canada, is expected to dominate the quinine market due to a high frequency of malaria and other mosquito-borne diseases. Additionally, the consumption of spirits like gin and tonic is on the rise.

Asia Pacific: The Asia Pacific region is projected to experience significant growth, driven by increased product approvals, rising awareness of malaria, and the consumption of spirits. India, China, and Indonesia are among the key markets driving demand.

Competitive Landscape

The quinine market is concentrated, with several major players driving innovation and expanding their distribution networks. Market consolidation is anticipated in the coming years. Some of the leading companies in the global quinine space include:

  • Aecochem Corp
  • Haihang Industry Co. Ltd.
  • Actavis
  • Shreeji Pharma International
  • Wockhardt
  • Vital Labs
  • Trademax Pharmaceuticals & Chemicals
  • Van Wankum Ingredients
  • Hangzhou Dayang Co. Ltd.
  • IS Chemical Technology Ltd.
  • Leocorno Enterprises
  • Bickford & Sons
  • Fever-Tree
  • Schweppes
  • Chempro Pharma Private Limited

Global Quinine Market is Segmented as Below:

By Type:

  • 200 mg
  • 300 mg
  • Other

By Application:

  • Problematic Leg Cramps
  • Malaria
  • Other

By Administration:

  • Oral Administration
  • Intramuscular Administration
  • Intravenous Administration
  • Others

By End User:

  • Hospitals
  • Clinics
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Quinine Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Quinine Market Outlook, 2018 - 2030

  • 3.1. Global Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. 200 mg
      • 3.1.1.2. 300 mg
      • 3.1.1.3. Other
  • 3.2. Global Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Problematic Leg Cramps
      • 3.2.1.2. Malaria
      • 3.2.1.3. Other
  • 3.3. Global Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oral Administration
      • 3.3.1.2. Intramuscular Administration
      • 3.3.1.3. Intravenous Administration
      • 3.3.1.4. Others
  • 3.4. Global Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights Snacks
      • 3.4.1.1. Hospitals
      • 3.4.1.2. Clinics
      • 3.4.1.3. Others
  • 3.5. Global Quinine Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Quinine Market Outlook, 2018 - 2030

  • 4.1. North America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. 200 mg
      • 4.1.1.2. 300 mg
      • 4.1.1.3. Other
  • 4.2. North America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Problematic Leg Cramps
      • 4.2.1.2. Malaria
      • 4.2.1.3. Other
  • 4.3. North America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oral Administration
      • 4.3.1.2. Intramuscular Administration
      • 4.3.1.3. Intravenous Administration
      • 4.3.1.4. Others
  • 4.4. North America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Clinics
      • 4.4.1.3. Others
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis
  • 4.5. North America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.2. U.S. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.3. U.S. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.4. U.S. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 4.5.1.5. Canada Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.6. Canada Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.7. Canada Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.8. Canada Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Quinine Market Outlook, 2018 - 2030

  • 5.1. Europe Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. 200 mg
      • 5.1.1.2. 300 mg
      • 5.1.1.3. Other
  • 5.2. Europe Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Problematic Leg Cramps
      • 5.2.1.2. Malaria
      • 5.2.1.3. Other
  • 5.3. Europe Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oral Administration
      • 5.3.1.2. Intramuscular Administration
      • 5.3.1.3. Intravenous Administration
      • 5.3.1.4. Others
  • 5.4. Europe Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Clinics
      • 5.4.1.3. Others
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis
  • 5.5. Europe Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.2. Germany Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.3. Germany Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.4. Germany Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.5. U.K. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.6. U.K. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.7. U.K. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.8. U.K. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.9. France Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.10. France Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.11. France Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.12. France Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.13. Italy Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.14. Italy Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.15. Italy Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.16. Italy Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.17. Turkey Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.18. Turkey Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.19. Turkey Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.20. Turkey Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.21. Russia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.22. Russia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.23. Russia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.24. Russia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.25. Rest of Europe Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.26. Rest of Europe Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.27. Rest of Europe Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.28. Rest of Europe Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Quinine Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. 200 mg
      • 6.1.1.2. 300 mg
      • 6.1.1.3. Other
  • 6.2. Asia Pacific Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Problematic Leg Cramps
      • 6.2.1.2. Malaria
      • 6.2.1.3. Other
  • 6.3. Asia Pacific Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oral Administration
      • 6.3.1.2. Intramuscular Administration
      • 6.3.1.3. Intravenous Administration
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Clinics
      • 6.4.1.3. Others
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis
  • 6.5. Asia Pacific Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.2. China Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.3. China Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.4. China Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.5. Japan Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.6. Japan Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.7. Japan Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.8. Japan Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.9. South Korea Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.10. South Korea Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.11. South Korea Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.12. South Korea Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.13. India Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.14. India Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.15. India Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.16. India Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.17. Southeast Asia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.18. Southeast Asia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.19. Southeast Asia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.20. Southeast Asia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.21. Rest of Asia Pacific Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.22. Rest of Asia Pacific Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.23. Rest of Asia Pacific Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.24. Rest of Asia Pacific Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Quinine Market Outlook, 2018 - 2030

  • 7.1. Latin America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. 200 mg
      • 7.1.1.2. 300 mg
      • 7.1.1.3. Other
  • 7.2. Latin America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Problematic Leg Cramps
      • 7.2.1.2. Malaria
      • 7.2.1.3. Other
  • 7.3. Latin America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oral Administration
      • 7.3.1.2. Intramuscular Administration
      • 7.3.1.3. Intravenous Administration
      • 7.3.1.4. Others
  • 7.4. Latin America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Clinics
      • 7.4.1.3. Others
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis
  • 7.5. Latin America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.2. Brazil Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.3. Brazil Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.4. Brazil Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.5. Mexico Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.6. Mexico Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.7. Mexico Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.8. Mexico Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.9. Argentina Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.10. Argentina Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.11. Argentina Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.12. Argentina Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.13. Rest of Latin America Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.14. Rest of Latin America Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.15. Rest of Latin America Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.16. Rest of Latin America Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Quinine Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. 200 mg
      • 8.1.1.2. 300 mg
      • 8.1.1.3. Other
  • 8.2. Middle East & Africa Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Problematic Leg Cramps
      • 8.2.1.2. Malaria
      • 8.2.1.3. Other
  • 8.3. Middle East & Africa Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oral Administration
      • 8.3.1.2. Intramuscular Administration
      • 8.3.1.3. Intravenous Administration
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Clinics
      • 8.4.1.3. Others
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Middle East & Africa Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.2. GCC Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.3. GCC Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.4. GCC Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.5. South Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.6. South Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.7. South Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.8. South Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.9. Egypt Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.10. Egypt Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.11. Egypt Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.12. Egypt Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.13. Nigeria Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.14. Nigeria Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.15. Nigeria Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.16. Nigeria Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.17. Rest of Middle East & Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.18. Rest of Middle East & Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.19. Rest of Middle East & Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.20. Rest of Middle East & Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs Application Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Aecochem Corp
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Haihang Industry Co. Ltd.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Actavis
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Shreeji Pharma International
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Wockhardt
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Vital Labs
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Trademax Pharmaceuticals & Chemicals
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Van Wankum Ingredients
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Hangzhou Dayang Co. Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Business Strategies and Development
    • 9.4.10. IS Chemical Technology Ltd.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Leocorno Enterprises
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Bickford & Sons
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Fever-Tree
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Schweppes
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Chempro Pharma Private Limited
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations